Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Batch Record Review and Product Release (Jan 13, 2026)" training has been added to ResearchAndMarkets.com's offering.This course shows how to review...
-
Downing LLPLEI: 213800G3X76VBG9SB50407 January 2026Form 8.3 re. Inspecs Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING...
-
Julie & Holleman LLP is investigating potential misconduct committed by Fiserv's directors and officers.
-
Julie & Holleman LLP is investigating potential misconduct at Stride, Inc.
-
GREENWICH, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO), a leading provider of freight transportation in North America, announced that it has renewed its long-standing commitment as the...
-
Julie & Holleman LLP is investigating potential misconduct by KinderCare's officers and directors.
-
Downing LLPLEI: 213800G3X76VBG9SB50407 January 2026Form 8.3 re. Frenkel Topping Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...
-
Downing LLPLEI: 213800G3X76VBG9SB50407 January 2026Form 8.3 re. 1Spatial Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR...
-
Name change to Kyntra Bio reflects the newly sharpened focus of the Company on novel therapies with potential for outsized impact in oncology and rare diseaseKyntra Bio will begin trading on Nasdaq...
-
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44th...